Budka H
Klinisches Institut für Neurologie, Universität Wien.
Wien Med Wochenschr. 1998;148(4):86-95.
Transmissible spongiform encephalopathies (TSEs) or prion diseases in man and animals are of utmost interest at present. Reasons are the highly probable origin from BSE of a new variant of Creutzfeldt-Jakob disease (CJD) in the UK and France, the new paradigm in biomedicine of the association of heredity and transmissibility, and the possible propagation of infectivity by protein only according to the prion hypothesis. Determination of the 14-3-3 protein in CSF and magnetic resonance imaging are promising new diagnostic tools; however, clinical examination yields only a suspect diagnosis, with formal criteria for "probable" or "possible" CJD. Definite diagnosis relies on neuropathology at autopsy or, in rare instances, brain biopsy. Handling of laboratory material from TSE patients requires specific measures of precaution and decontamination. Although blood and blood products have been shown to transmit disease, experimental and epidemiologic data for disease transmission via blood transfusion are lacking. New WHO regulations define exclusion criteria for blood donors. A special situation applies to the UK because the distribution of infectivity in the new CJD variant might differ from that of classical TSEs; therefore leukodepletion of blood donations was recommended.
目前,人类和动物的传染性海绵状脑病(TSEs)或朊病毒疾病备受关注。原因在于英国和法国新变异型克雅氏病(CJD)极有可能源于牛海绵状脑病,在于遗传与传染性关联这一生物医学新范式,还在于仅根据朊病毒假说蛋白质可能具有传染性传播。脑脊液中14-3-3蛋白的测定和磁共振成像都是很有前景的新诊断工具;然而,临床检查仅能做出疑似诊断,有“可能”或“疑似”CJD的正式标准。确诊依赖尸检时的神经病理学检查,或在极少数情况下依赖脑活检。处理来自TSE患者的实验室材料需要采取特定的预防和去污措施。尽管血液和血液制品已被证明可传播疾病,但缺乏通过输血传播疾病的实验和流行病学数据。世界卫生组织的新规定明确了献血者的排除标准。英国的情况特殊,因为新变异型CJD中传染性的分布可能与经典TSEs不同;因此建议对献血进行白细胞去除处理。